Cabozantinib in Patients with Advanced Merkel Cell Carcinoma
Guilherme Rabinowits(Baptist Hospital of Miami), James A. DeCaprio(Harvard University), Hailey Becker(Dana-Farber Cancer Institute), Paul J. Catalano(Computational Physics (United States)), Ayushi Tyagi(Dana-Farber Cancer Institute), Patricia McHugh(Dana-Farber Cancer Institute), Cecilia Lezcano(Memorial Sloan Kettering Cancer Center), Robert I. Haddad(Georgetown University), Lynette M. Sholl(Brigham and Women's Hospital), Scott C. Bresler(Brigham and Women's Hospital), Manisha Thakuria(Brigham and Women's Hospital), Julian Huang(Yale University), Geoffrey I. Shapiro(Brigham and Women's Hospital)
Cited by 36
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k